Product Information
- 1-(2-Deoxy-2-cyano-b-D-arabinofuranosyl)cytosine
- 1-(2-cyano-2-deoxy-beta-D-arabinofuranosyl)-4-(hexadecanoylamino)pyrimidin-2(1H)-one
- Cs-682
- Cyc 682
- Hexadecanamide, N-[1-(2-cyano-2-deoxy-β-<span class="text-smallcaps">D</span>-arabinofuranosyl)-1,2-dihydro-2-oxo-4-pyrimidinyl]-
- N-[1-(2-Cyano-2-deoxy-β-<span class="text-smallcaps">D</span>-arabinofuranosyl)-1,2-dihydro-2-oxo-4-pyrimidinyl]hexadecanamide
- N-[1-[(2R,3S,4S,5R)-3-cyano-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2- oxo-pyrimidin-4-yl]hexadecanamide
- N-[1-(2-Cyano-2-deoxy-β-D-arabinofuranosyl)-1,2-dihydro-2-oxo-4-pyrimidinyl]hexadecanamide
- Hexadecanamide, N-[1-(2-cyano-2-deoxy-β-D-arabinofuranosyl)-1,2-dihydro-2-oxo-4-pyrimidinyl]-
Sapacitabine is an oral prodrug that is converted to its active form, the cytotoxic agent 9-β-D-arabinofuranosyladenine (araA), by cellular enzymes. It has potent antitumor activity against solid tumours and has been shown to be effective in a variety of human cancer cell lines. Sapacitabine targets intracellular targets, including DNA methyltransferases and other enzymes involved in the synthesis of RNA and DNA. The drug has been shown to have synergistic effects when used with other cytotoxic agents such as 5-fluorouracil and gemcitabine, which are also inhibitors of DNA methyltransferase.
Chemical properties
Technical inquiry about: 3D-NS29828 Sapacitabine
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
